Literature DB >> 6975352

Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.

A C Aisenberg, K J Bloch, B M Wilkes.   

Abstract

In the course of analyzing human lymphoma tissue with conventional surface marker techniques and with monoclonal antibodies directed against T cell subsets, five tumors were encountered with dual B and T cell determinants. All bore on their surface membrane IgM of kappa light chain type, complement receptors, and the Ia-like antigen. In each of the five cases, the neoplastic lymphocytes reacted with a monoclonal antibody that detects the sheep erythrocyte receptor (OKT11); all but one reacted with a monoclonal antibody for peripheral T cells (OKT3); and all but one reacted with a monoclonal antibody specific for either the inducer-helper (OKT4) or the cytotoxic-suppressor (OKT8) T cell subsets. In addition, lymphocytes from two of the five cases formed spontaneous rosettes with sheep erythrocytes (E-rosettes). These tumors with dual B and T surface characteristics were confined to human malignant lymphomas that originate from B lymphocytes of the follicle center.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975352      PMCID: PMC2186513          DOI: 10.1084/jem.154.5.1709

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  LYMPHOSARCOMA CELL LEUKEMIA.

Authors:  D L SCHWARTZ; R V PIERRE; P P SCHEERER; E C REED; J W LINMAN
Journal:  Am J Med       Date:  1965-05       Impact factor: 4.965

Review 2.  The human Ia system.

Authors:  R J Winchester; H G Kunkel
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

3.  Evidence for individual human peripheral blood lymphocytes bearing both B and T cell markers.

Authors:  H B Dickler; N F Adkinson; W D Terry
Journal:  Nature       Date:  1974-01-25       Impact factor: 49.962

4.  Increased proportion of complement-receptor lymphocytes in the peripheral blood of patients with chronic lymphocytic leukemia.

Authors:  S Pincus; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1972-09       Impact factor: 22.113

5.  Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.

Authors:  A C Aisenberg
Journal:  N Engl J Med       Date:  1981-02-05       Impact factor: 91.245

6.  Strategies for generating monoclonal antibodies defining human t-lymphocyte differentiation antigens.

Authors:  P C Kung; M A Talle; M E DeMaria; M S Butler; J Lifter; G Goldstein
Journal:  Transplant Proc       Date:  1980-09       Impact factor: 1.066

7.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.

Authors:  E L Reinherz; P C Kung; G Goldstein; R H Levey; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

8.  Distribution of T cell subsets in human lymph nodes.

Authors:  S Poppema; A K Bhan; E L Reinherz; R T McCluskey; S F Schlossman
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

9.  An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells.

Authors:  L Boumsell; H Coppin; D Pham; B Raynal; J Lemerle; J Dausset; A Bernard
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

10.  Unusual human lymphoma phenotype defined by monoclonal antibody.

Authors:  A C Aisenberg; B M Wilkes
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  14 in total

1.  Appearance of the T-cell marker CD8 on B chronic lymphatic leukemia cells in long-term cultures.

Authors:  R Farkas; S Ben-Efraim; Y Manor; I Zan-Bar; A Klajman
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Expression of T3 and T11 determinants on human peripheral lymphocytes as analysed by the indirect antiglobulin rosetting reaction (IARR) and indirect immunofluorescence.

Authors:  D G Haegert
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

3.  CD4-positive diffuse large B cell lymphoma identified by flow cytometry: two case reports.

Authors:  Marisa Arrondini; Antonella Barreca; Sabrina Aliberti; Anna Demurtas; Fabrizio Tondat; Domenico Novero; Alessandra Stacchini
Journal:  Int J Hematol       Date:  2010-06-25       Impact factor: 2.490

4.  A monoclonal surface immunoglobulin (IgM/D-L) with specificity for surface antigen of ox red blood cells in a patient with leukemic lymphosarcoma.

Authors:  S Shimizu; S Sugai; S Konda; Y Yamanaka; M Setoyama
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

5.  Biological effects of antibodies to lymphocyte surface receptors.

Authors:  J W Goding
Journal:  Springer Semin Immunopathol       Date:  1982

6.  Expression of a T-cell antigen (Leu-1) by B-cell lymphomas.

Authors:  B F Burns; R A Warnke; R S Doggett; R V Rouse
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

7.  Immunoglobulin mu-chain gene rearrangement in a patient with T cell acute lymphoblastic leukemia.

Authors:  K Ha; M Minden; N Hozumi; E W Gelfand
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).

Authors:  T Al Saati; G Laurent; P Caveriviere; F Rigal; G Delsol
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

9.  Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse.

Authors:  S H Swerdlow; J A Habeshaw; L J Murray; H S Dhaliwal; T A Lister; A G Stansfeld
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

10.  Distribution of T-cell subsets in follicular and diffuse lymphomas of B-cell type.

Authors:  N L Harris; A K Bhan
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.